DISPOSITION OF MEPIVACAINE AND BUPIVACAINE ENANTIOMERS IN SHEEP

被引:51
|
作者
MATHER, LE [1 ]
机构
[1] FLINDERS UNIV,MED CTR,DEPT ANAESTHESIA & INTENS CARE,BEDFORD PK,SA 5042,AUSTRALIA
基金
英国医学研究理事会;
关键词
ANESTHETICS; LOCAL; MEPIVACAINE; BUPIVACAINE; BIOTRANSFORMATION; STEREOISOMERS; PHARMACOKINETICS; EXTRACTION RATIO;
D O I
10.1093/bja/67.3.239
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Mepivacaine and bupivacaine are used clinically as racemic mixtures of enantiomers. In these studies the enantiomers of each agent were administered separately to sheep by i.v. bolus injection on separate occasions. Enantioselective disposition was deemed if the R:S ratio of the relevant pharmacokinetic parameter differed significantly from unity. Both enantiomers of both agents were cleared principally by the liver; urinary excretion of unmetabolized agents accounted for < 2% of the doses. For R(-)- and S(+)-mepivacaine, respective mean (SEM) values of parameters were: total body clearance 1.20 (0.29) litre min-1 and 0.97 (0.20) litre min-1 (ns); total volume of distribution 144 (39) litre and 80 (21) litre (P < 0.05); slow halflife 120 (40) min and 84 (22) min (ns); mean hepatic extraction ratio 0.50 (0.14) and 0.52 (0.09) (ns); mean hepatic clearance 0.75 (0.23) litre min-1 and 0.75 (0.18) litre min-1 (ns). For R(+)- and S(-)-bupivacaine, respective values were: total body clearance 0.77 (0.33) litre min-1 and 0.53 (0.26) litre min-1 (P < 0.05); total volume of distribution 40 (10) litre and 43 (10) litre (ns); slow half-life 57 (10) min and 104 (21) min (P < 0.05); mean hepatic extraction ratio 0.46 (0.15) and 0.29 (0.13) (P < 0.05); mean hepatic clearance 0.85 (0.31) litre min-1 and 0.54 (0.26) litre min-1 (P < 0.05). Thus there was enantioselective distribution of mepivacaine and enantioselective clearance of bupivacaine, but the magnitude of the effect was relatively small.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 50 条
  • [1] Pharmacokinetics of the enantiomers of bupivacaine and mepivacaine after epidural administration of the racemates
    Groen, K
    Mantel, M
    Zeijlmans, PWM
    Zeppenfeldt, B
    Olieman, W
    Stienstra, R
    van Kleef, JW
    Burm, AGL
    ANESTHESIA AND ANALGESIA, 1998, 86 (02): : 361 - 366
  • [2] TISSUE DISTRIBUTION OF BUPIVACAINE ENANTIOMERS IN SHEEP
    RUTTEN, AJ
    MATHER, LE
    MCLEAN, CF
    NANCARROW, C
    CHIRALITY, 1993, 5 (07) : 485 - 491
  • [3] TRANSPULMONARY DISPOSITION OF PRILOCAINE, MEPIVACAINE, AND BUPIVACAINE IN HUMANS IN THE COURSE OF EPIDURAL-ANESTHESIA
    KIETZMANN, D
    FOTH, H
    GENG, WP
    RATHGEBER, J
    GUNDERTREMY, U
    KETTLER, D
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1995, 39 (07) : 885 - 890
  • [4] Systemic and regional pharmacokinetics of levobupivacaine and bupivacaine enantiomers in sheep
    Mather, LE
    Huang, YF
    Veering, B
    Pryor, ME
    ANESTHESIA AND ANALGESIA, 1998, 86 (04): : 805 - 811
  • [5] OPTICAL ISOMERS OF MEPIVACAINE AND BUPIVACAINE
    LUDUENA, FP
    BOGADO, EF
    TULLAR, BF
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1972, 200 (02): : 359 - 369
  • [6] OPTICAL ISOMERS OF MEPIVACAINE AND BUPIVACAINE
    TULLAR, BF
    JOURNAL OF MEDICINAL CHEMISTRY, 1971, 14 (09) : 891 - &
  • [7] PHARMACOKINETICS OF BUPIVACAINE ENANTIOMERS IN SHEEP - INFLUENCE OF DOSAGE REGIMEN AND STUDY DESIGN
    MATHER, LE
    RUTTEN, AJ
    PLUMMER, JL
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1994, 22 (06): : 481 - 498
  • [8] SPINAL ANALGESIA WITH BUPIVACAINE, MEPIVACAINE AND TETRACAINE
    BENGTSSON, M
    EDSTROM, HH
    LOFSTROM, JB
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1983, 27 (03) : 278 - 283
  • [10] INFLUENCE OF BUPIVACAINE ON MEPIVACAINE PROTEIN-BINDING
    HARTRICK, CT
    DIRKES, WE
    COYLE, DE
    RAJ, PP
    DENSON, DD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (04) : 546 - 550